https://www.selleckchem.com/pr....oducts/plerixafor-8h
COVID-19 pandemic compared with the same time period in the previous 2 years. These preliminary results from a cardiovascular regional public service healthcare hub demonstrate a significantly longer time from symptoms onset to hospital admission among patients with STEMI during COVID-19 pandemic compared with the same time period in the previous 2 years. Low-density lipoproteins (LDLs) are removed by extracorporeal filtration during LDL apheresis. It is mainly used in familial hyperlipidemia. The PREMIER trial (Plaque R
Curtir
Comentario
Compartilhar
